相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The dysregulation of endoplasmic reticulum stress response in acute-on-chronic liver failure patients caused by acute exacerbation of chronic hepatitis B
F. Ren et al.
JOURNAL OF VIRAL HEPATITIS (2016)
Fibroblast growth factor 21 induction by activating transcription factor 4 is regulated through three amino acid response elements in its promoter region
Ryuto Maruyama et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2016)
Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver Transplantation
Dewei Ye et al.
SCIENTIFIC REPORTS (2016)
Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding
Kathleen R. Markan et al.
DIABETES (2014)
Fibroblast Growth Factor 21 Protects Against Acetaminophen-Induced Hepatotoxicity by Potentiating Peroxisome Proliferator-Activated Receptor Coactivator Protein-1α-Mediated Antioxidant Capacity in Mice
Dewei Ye et al.
HEPATOLOGY (2014)
Fibroblast Growth Factor 21 Is Regulated by the IRE1α-XBP1 Branch of the Unfolded Protein Response and Counteracts Endoplasmic Reticulum Stress-induced Hepatic Steatosis
Shan Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
ATF4-and CHOP-Dependent Induction of FGF21 through Endoplasmic Reticulum Stress
Xiao-shan Wan et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Fibroblast growth factor 21 is induced by endoplasmic reticulum stress
Frank G. Schaap et al.
BIOCHIMIE (2013)
Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress
Chaofeng Yang et al.
BMC GASTROENTEROLOGY (2013)
High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: A 3-year prospective study in China
Huating Li et al.
JOURNAL OF HEPATOLOGY (2013)
βKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and Metabolism
Xunshan Ding et al.
CELL METABOLISM (2012)
Distinct Changes in Serum Fibroblast Growth Factor 21 Levels in Different Subtypes of Diabetes
Yang Xiao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Serum FGF21 and RBP4 levels in patients with chronic hepatitis C
Michal Kukla et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
J. J. Ott et al.
VACCINE (2012)
Alteration of Hepatic Nuclear Receptor-Mediated Signaling Pathways in Hepatitis C Virus Patients With and Without a History of Alcohol Drinking
Chuanghong Wu et al.
HEPATOLOGY (2011)
Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study
Hongmei Yan et al.
PLOS ONE (2011)
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis European Association for the Study of the Liver
Pere Gines et al.
JOURNAL OF HEPATOLOGY (2010)
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)
Shiv Kumar Sarin et al.
HEPATOLOGY INTERNATIONAL (2009)
Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease
W. Ray Kim et al.
HEPATOLOGY (2008)
Expression of hepatitis B virus proteins in transgenic mice alters lipid metabolism and induces oxidative stress in the liver
Fu Yang et al.
JOURNAL OF HEPATOLOGY (2008)
Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response 10.1016/j.virusres.2006.09.01
Baozong Li et al.
VIRUS RESEARCH (2007)
Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis
Xinqiang Huang et al.
MOLECULAR CARCINOGENESIS (2006)
Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis
Hui-Ching Wang et al.
CANCER SCIENCE (2006)
Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005
HJ Yim et al.
HEPATOLOGY (2006)
Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention
D. Lavanchy
JOURNAL OF CLINICAL VIROLOGY (2005)
分享论文
